# Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain

> **NCT02985216** · PHASE3 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 371 (actual)

## Conditions studied

- Peripheral Neuropathic Pain

## Interventions

- **DRUG:** YHD1119
- **DRUG:** Lyrica

## Key facts

- **NCT ID:** NCT02985216
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-07
- **Primary completion:** 2018-04-27
- **Final completion:** 2018-05-02
- **Target enrollment:** 371 (ACTUAL)
- **Last updated:** 2019-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02985216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02985216, "Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02985216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*